Switch theme
Sign up to access all valuation multiples
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
2020
3
Last FY Revenue $0.4M
Last FY EBITDA $0.4M
$9.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Biogena Gr Inv achieved revenue of $0.4M and an EBITDA of $0.4M.
Biogena Gr Inv expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Biogena Gr Inv valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.4M | XXX | XXX | XXX |
| Gross Profit | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | XXX | n/a | XXX | XXX | XXX |
| EBITDA | XXX | $0.4M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 91% | XXX | XXX | XXX |
| EBIT | XXX | $0.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | 53% | XXX | XXX | XXX |
| Net Profit | XXX | $0.4M | XXX | XXX | XXX |
| Net Margin | XXX | 90% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Biogena Gr Inv's stock price is EUR 2 (or $2).
Biogena Gr Inv has current market cap of EUR 8.4M (or $9.4M), and EV of EUR 8.4M (or $9.4M).
See Biogena Gr Inv trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9.4M | $9.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Biogena Gr Inv has market cap of $9.4M and EV of $9.4M.
Biogena Gr Inv's trades at 22.7x EV/Revenue multiple, and 25.1x EV/EBITDA.
Equity research analysts estimate Biogena Gr Inv's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biogena Gr Inv's P/E ratio is not available.
See valuation multiples for Biogena Gr Inv and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9.4M | XXX | $9.4M | XXX | XXX | XXX |
| EV (current) | $9.4M | XXX | $9.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 22.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 25.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 42.8x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 25.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -929.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBiogena Gr Inv's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Biogena Gr Inv's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Biogena Gr Inv's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Biogena Gr Inv and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 91% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Agthia Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
| ForFarmers | XXX | XXX | XXX | XXX | XXX | XXX |
| JDE Peets | XXX | XXX | XXX | XXX | XXX | XXX |
| Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biogena Gr Inv acquired XXX companies to date.
Last acquisition by Biogena Gr Inv was XXXXXXXX, XXXXX XXXXX XXXXXX . Biogena Gr Inv acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Biogena Gr Inv founded? | Biogena Gr Inv was founded in 2020. |
| Where is Biogena Gr Inv headquartered? | Biogena Gr Inv is headquartered in Austria. |
| How many employees does Biogena Gr Inv have? | As of today, Biogena Gr Inv has 3 employees. |
| Is Biogena Gr Inv publicy listed? | Yes, Biogena Gr Inv is a public company listed on WBO. |
| What is the stock symbol of Biogena Gr Inv? | Biogena Gr Inv trades under BIO ticker. |
| When did Biogena Gr Inv go public? | Biogena Gr Inv went public in 2020. |
| Who are competitors of Biogena Gr Inv? | Similar companies to Biogena Gr Inv include e.g. Agthia Group, Acomo, ForFarmers, JDE Peets. |
| What is the current market cap of Biogena Gr Inv? | Biogena Gr Inv's current market cap is $9.4M |
| Is Biogena Gr Inv profitable? | Yes, Biogena Gr Inv is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
